Stockscreener 앱 받기
1.24%
시간 외 거래:
전일 마감가:
$284.70
열려 있는:
$283.49
하루 거래량:
1.80M
Relative Volume:
0.70
시가총액:
$154.98B
수익:
$34.92B
순이익/손실:
$6.62B
주가수익비율:
23.57
EPS:
12.23
순현금흐름:
$10.61B
1주 성능:
-2.91%
1개월 성능:
-2.95%
6개월 성능:
-1.81%
1년 성능:
-11.23%
1일 변동 폭
$283.49
$288.49
1주일 범위
$281.65
$302.33
52주 변동 폭
$253.30
$339.17
암젠 Stock (AMGN) Company Profile
명칭
Amgen Inc
전화
(805)447-1000
주소
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
AMGN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AMGN
Amgen Inc
|
288.23 | 153.26B | 34.92B | 6.62B | 10.61B | 12.23 |
|
LLY
Lilly Eli Co
|
625.65 | 670.04B | 53.26B | 13.80B | -50.20M | 15.30 |
|
JNJ
Johnson Johnson
|
173.33 | 410.84B | 90.63B | 22.66B | 16.40B | 9.35 |
|
ABBV
Abbvie Inc
|
198.05 | 346.78B | 58.33B | 3.76B | 18.24B | 2.10 |
|
NVS
Novartis Ag Adr
|
116.84 | 219.72B | 55.19B | 13.65B | 16.81B | 6.86 |
|
MRK
Merck Co Inc
|
80.69 | 198.42B | 63.62B | 16.41B | 14.72B | 6.49 |
암젠 Stock (AMGN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-20 | 재개 | Guggenheim | Neutral |
| 2025-04-22 | 재개 | Cantor Fitzgerald | Neutral |
| 2024-12-10 | 재개 | BofA Securities | Underperform |
| 2024-11-15 | 개시 | Wolfe Research | Peer Perform |
| 2024-11-14 | 개시 | Citigroup | Neutral |
| 2024-10-17 | 개시 | Bernstein | Outperform |
| 2024-10-14 | 다운그레이드 | Truist | Buy → Hold |
| 2024-09-27 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-08-07 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2024-05-03 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2024-05-03 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2024-03-28 | 재개 | Raymond James | Mkt Perform |
| 2024-02-07 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2023-12-21 | 업그레이드 | Daiwa Securities | Neutral → Buy |
| 2023-12-19 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2023-12-12 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-11-09 | 개시 | Deutsche Bank | Hold |
| 2023-11-02 | 업그레이드 | Truist | Hold → Buy |
| 2023-10-20 | 재개 | JP Morgan | Neutral |
| 2023-10-17 | 재개 | Morgan Stanley | Equal-Weight |
| 2023-10-11 | 재개 | BofA Securities | Neutral |
| 2023-09-06 | 개시 | HSBC Securities | Buy |
| 2023-04-24 | 재확인 | Oppenheimer | Outperform |
| 2023-03-13 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-02-13 | 재확인 | Truist | Buy |
| 2022-11-18 | 개시 | Credit Suisse | Underperform |
| 2022-10-31 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2022-10-11 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2022-05-23 | 개시 | SVB Leerink | Mkt Perform |
| 2022-02-09 | 재확인 | Barclays | Equal Weight |
| 2022-02-09 | 재확인 | Jefferies | Buy |
| 2022-02-09 | 재확인 | Morgan Stanley | Equal-Weight |
| 2022-02-09 | 재확인 | Oppenheimer | Outperform |
| 2022-02-09 | 재확인 | Wells Fargo | Equal Weight |
| 2022-01-05 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2021-12-09 | 재개 | Wells Fargo | Equal Weight |
| 2021-12-06 | 개시 | Goldman | Buy |
| 2021-11-19 | 개시 | BMO Capital Markets | Market Perform |
| 2021-09-23 | 다운그레이드 | Daiwa Securities | Outperform → Neutral |
| 2021-09-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-29 | 개시 | Daiwa Securities | Buy |
| 2020-10-28 | 개시 | UBS | Neutral |
| 2020-10-26 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-10-12 | 업그레이드 | Truist | Hold → Buy |
| 2020-10-09 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2020-10-09 | 다운그레이드 | Truist | Buy → Hold |
| 2020-10-08 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2020-04-15 | 재개 | Guggenheim | Neutral |
| 2020-03-31 | 개시 | Wolfe Research | Peer Perform |
| 2020-03-30 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-03-05 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2020-02-27 | 개시 | Barclays | Equal Weight |
| 2020-01-31 | 다운그레이드 | Robert W. Baird | Neutral → Underperform |
| 2020-01-21 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2019-12-24 | 개시 | Raymond James | Mkt Perform |
| 2019-12-17 | 재개 | Morgan Stanley | Overweight |
| 2019-11-12 | 개시 | SunTrust | Buy |
| 2019-11-05 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2019-10-17 | 재개 | BofA/Merrill | Neutral |
| 2019-08-19 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2019-05-23 | 업그레이드 | Citigroup | Neutral → Buy |
모두보기
암젠 주식(AMGN)의 최신 뉴스
Q3 Earnings Forecast for Amgen Issued By Leerink Partnrs - MarketBeat
What is William Blair's Estimate for Amgen FY2025 Earnings? - MarketBeat
WealthPlan Investment Management LLC Purchases 2,170 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Beacon Harbor Wealth Advisors Inc. Raises Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Deutsche Bank AG Purchases 52,734 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Ontario Teachers Pension Plan Board Purchases 6,837 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
ASR Vermogensbeheer N.V. Buys New Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Westwood Holdings Group Inc. Raises Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen (NASDAQ:AMGN) Price Target Raised to $310.00 at Citigroup - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Bought by Altfest L J & Co. Inc. - MarketBeat
Mizuho Securities USA LLC Sells 7,932 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Holdings Lifted by Frank Rimerman Advisors LLC - MarketBeat
4,229 Shares in Amgen Inc. (NASDAQ:AMGN) Bought by Koss Olinger Consulting LLC - MarketBeat
Townsquare Capital LLC Buys 8,789 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Donoghue Forlines LLC Cuts Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen (NASDAQ:AMGN) Announces Earnings Results, Beats Expectations By $0.74 EPS - MarketBeat
National Bank of Canada FI Has $64.10 Million Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Chicago Partners Investment Group LLC Buys 1,019 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Cary Street Partners Investment Advisory LLC Has $424,000 Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen (NASDAQ:AMGN) Updates FY 2025 Earnings Guidance - MarketBeat
Amgen (NASDAQ:AMGN) Lowered to Hold Rating by Wall Street Zen - MarketBeat
FY2027 Earnings Forecast for Amgen Issued By Leerink Partnrs - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Q2 2025 Earnings Call Transcript - MSN
William Blair Has Pessimistic Outlook of Amgen Q3 Earnings - MarketBeat
Zions Bancorporation National Association UT Buys Shares of 31,514 Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Acquired by Savvy Advisors Inc. - MarketBeat
Hudson Canyon Capital Management Makes New Investment in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
AlphaCore Capital LLC Has $2.72 Million Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Did Strong Q2 Results and Upbeat Guidance Just Shift Amgen's (AMGN) Earnings Outlook? - simplywall.st
Stock Analysis | Amgen OutlookTechnical Weakness Looms as Mixed Analyst Sentiment Prevails - AInvest
Amgen's Repatha, Evenity & Blincyto Drive Sales This Earnings Season - MSN
Amgen’s New Clinical Trial: A Potential Game-Changer in Autoimmune Disease Treatment - TipRanks
Amgen’s Promising Study on Romosozumab for Osteogenesis Imperfecta - TipRanks
Banco Santander S.A. Raises Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Mitsubishi UFJ Asset Management Co. Ltd. Has $348.34 Million Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Fayez Sarofim & Co Increases Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Maryland State Retirement & Pension System Sells 3,948 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Raiffeisen Bank International AG Boosts Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Citizens Financial Group Inc. RI Cuts Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen’s Promising Obesity Treatment Study: Key Insights for Investors - TipRanks
CytomX (CTMX) Q2 Revenue Drops 26% - The Motley Fool
NewEdge Wealth LLC Raises Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Precision Trading with Amgen Inc. (AMGN) Risk Zones - news.stocktradersdaily.com
Generative AI Tools Support Amgen’s Mission to Serve Patients - Amgen
Morgan Stanley Forecasts Strong Price Appreciation for Amgen (NASDAQ:AMGN) Stock - MarketBeat
NJ State Employees Deferred Compensation Plan Lowers Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen and AstraZeneca’s HORIZON Study: A New Hope for Pediatric Asthma - TipRanks
Amgen’s New Study: A Potential Game-Changer in Lung Cancer Treatment? - TipRanks
Amgen’s Promising Phase 3 Study on Avacopan for Pediatric AAV - TipRanks
Amgen’s Rocatinlimab Study: A Potential Game-Changer for Atopic Dermatitis - TipRanks
Amgen’s MARITIME-2 Study: A Potential Game-Changer in Diabetes Treatment - TipRanks
암젠 (AMGN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
8.28%
0.63%
자본화:
|
볼륨(24시간):